.png){kind=small}
Proposed mechanism
Research on thymosin beta-4 describes interactions with actin, cell migration, blood-vessel signaling, and inflammatory pathways. How a marketed TB-500 product behaves in humans is not established.
PHYSICIAN-LED PEPTIDE EVIDENCE REVIEW
TB-500: How It Works, What the Research Shows, and Where It Stands Today
TB-500 is a synthetic peptide modeled on the active region of thymosin beta-4, a naturally occurring protein involved in cell movement, tissue organization, and repair signaling. Most research remains preclinical, and TB-500 is not FDA-approved for any medical use.
A consultation does not guarantee a prescription. Availability depends on current law, sourcing, and clinical appropriateness.
Timothy Mackey, D.O.
Physician-led evaluation and monitoring
PHYSICIAN LED
Individual evaluation
Individual evaluation
FLORIDA
License OS9185
License OS9185
★★★★★
4.9 Google rating
4.9 Google rating
A+ BBB
Accredited business
Accredited business
Current status: NovaGenix does not currently offer or sell TB-500. The clinic can evaluate the underlying concern, explain the evidence and regulatory landscape, and discuss lawful, medically appropriate alternatives.
What TB-500 is—and what it is not
TB-500 is not the full thymosin beta-4 protein. It is a shorter synthetic fragment promoted for recovery, tendon and ligament concerns, inflammation, and wound healing. Laboratory and animal findings help explain the interest, but they do not establish that TB-500 safely treats injuries in people.
Human evidence
High-quality clinical trials of TB-500 for musculoskeletal recovery are lacking. Dosing, effectiveness, and long-term safety remain uncertain.
Regulatory status
TB-500 is not FDA-approved. Patients should not equate online availability, a research label, or a clinician discussion with FDA review.
TB-500 and BPC-157 are not interchangeable
They are frequently discussed together online, sometimes as the “Wolverine Stack,” but they are different experimental peptides with different proposed pathways and evidence bases.
| Question | TB-500 | BPC-157 |
|---|---|---|
| What is it? | Synthetic fragment modeled on thymosin beta-4 | Synthetic peptide derived from a gastric protein sequence |
| Human injury evidence | Very limited | Limited; most evidence remains preclinical |
| FDA-approved? | No | No |
| Competitive sport | Anti-doping restrictions may apply | Listed by WADA as a non-approved substance |
Safety, sourcing, and anti-doping concerns
- Unapproved products may have uncertain identity, potency, purity, or sterility.
- Potential risks, interactions, immune reactions, and long-term effects are not well defined.
- There is no standardized, FDA-reviewed TB-500 dose or product for injury recovery.
- Competitive athletes should verify WADA and governing-body rules before using any peptide.
Do not buy injectable peptides from social media, overseas sellers, or websites marked “research use only.” Call 911 for an emergency and contact a clinician promptly for concerning symptoms.
What a physician-led consultation can accomplish
Clarify the diagnosis
Review symptoms, imaging, training load, medications, health history, and prior rehabilitation.
Compare appropriate options
Discuss established treatments, supportive care, and investigational options without overstating certainty.
Plan follow-up
When treatment is appropriate and lawfully available, define monitoring, stop criteria, and next steps.
Frequently asked questions
Is TB-500 FDA-approved?
No. TB-500 is not FDA-approved for any indication.
Does TB-500 heal tendons or ligaments?
That claim has not been established in robust human trials. Preclinical findings are not proof of clinical benefit.
Can NovaGenix prescribe TB-500?
NovaGenix does not currently offer or sell TB-500. A physician can assess your concern and discuss current lawful options.
Is TB-500 permitted in sports?
Athletes should assume anti-doping rules may apply and verify the current WADA list and their sport’s policies.
Start with a physician conversation
Discuss your recovery concern, medical history, current evidence, and appropriate options with Timothy Mackey, D.O.